Close
CDMO Safety Testing 2026
Novotech

FPS Food and Pharma Systems Announces Production Plant Expansions

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

MGS Advances Healthcare Product Development with Hybrid Tooling

MGS, a healthcare-focused contract development and manufacturing organization, has...

Daewoong and Chime Biologics Partner for Biosimilar Push

Chime Biologics and Daewoong Pharmaceutical have entered into a...

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has...
- Advertisement -

FPS Food and Pharma Systems has announced it is expanding its production plant in Fiorenzuola d’Arda for greater flexibility and timeliness on production systems.

A leading company in design, manufacture, and installation of fine size reduction machines for micronising and containment solutions for sterile and/or highly potent active pharmaceutical ingredients (API), FPS Food and Pharma Systems has disclosed the beginning of the plant’s enlargement in Fiorenzuola d’Arda.

The expansion is designed to improve the production process management and allow a significant increase in production capacity.

Adjacent to the current facility, the new area is composed of approximately 3000m2 covered and 3000m2 uncovered land, which will be dedicated to the assembly and testing of FPS’ systems. A further area will be dedicated to the assembly execution and storage of mock-up.

An equipped cafeteria and training classroom will also be available soon, with technical workshops planned for 2017.

The venue was recently enlarged and modernised with the construction of a new offices area and a research and development (R&D) test centre. The facilities’ redesigns help it adapt to the company’s needs.

FPS Food and Pharma Services’ vice-president and technical manager Carlo Corsini said: “It’s been months since the inauguration of the new area dedicated to the R&D and Test Center but, the steady development, has made necessary to plan, in few time, new works programed with foresight and carried out with determination in order to strengthen the logistics structure.”

ย The company’s president Giovanni Gianola added: “With the increase of production capacity of the site of Fiorenzuola d’Arda Plant, FPS renews its commitment to the improvement and development of micronisation and fine grinding systems, as well as containment solutions.

“We are proud of Italian excellence; we can confirm the current employment level and to show to our territory the new factory, which will allow us to be even more competitive for the benefit of our customers.”

World Pharma Today brings together the global pharmaceutical industry โ€” from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

MGS Advances Healthcare Product Development with Hybrid Tooling

MGS, a healthcare-focused contract development and manufacturing organization, has...

Daewoong and Chime Biologics Partner for Biosimilar Push

Chime Biologics and Daewoong Pharmaceutical have entered into a...

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has...

Aragen Achieves Daretabart Commercial-scale GMP Production

Aragen, a global leader in Contract Research, Development, and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป